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Chapter 1-Introduction
Endoplasmic Reticulum
The Endoplasmic Reticulum (ER) is an organelle in eukaryotic cells that plays a key role
in the production and folding of proteins [1]. Approximately one third of the total proteins in
eukaryotes are produced in the ER membrane [2]. In order to synthesize proteins, ribosomes
localize on the cytosol-facing side of the ER [3]. Then, the ribosomes translate the sequences
encoded by messenger RNA (mRNA) into proteins through the use of transfer RNA (tRNA)
anticodons [4]. Additionally, while the ribosomes face the cytosol, the synthesized polypeptides
are translocated either cotranslationally with the assistance of the Signal Recognition Particle
(SRP) or posttranslationally with the aid of Heat shock proteins (Hsp) to cross the membrane
back into the ER [5].
After the polypeptide sequences are synthesized and translocated to the ER, they undergo
folding to reach their native state, which is the conformation in which the Gibbs free energy is at
its lowest [6]. This process is guided by chaperone proteins (typically Hsp proteins) and lectin
chaperones that bind to the polypeptides while they are still folding in order to facilitate
progression to the native state and can be catalyzed by the presence of protein disulfide
isomerases, which assist covalent bond formation [6]. For many proteins, proper folding cannot
occur without undergoing a process called glycosylation, which will be explained next.
Glycosylation
For a class of proteins called glycoproteins, proper folding of the polypeptides is aided by
the addition of glycans to their structures after they enter the ER membrane [7]. A common form
of glycosylation that occurs in the ER is N-linked glycosylation, which is a cotranslational
process that links glycans to the nitrogen portion of Asn residues shortly after the polypeptide
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strand begins to enter the ER as facilitated by the oligosaccharyl transferase (OST) [8]. After the
glycan is transferred to the protein, it undergoes mannosidase trimming by glucosidase I and II in
order to open up sites for binding by the relevant chaperone proteins [9]. These chaperones,
calnexin and calreticulin, help prevent protein aggregation by binding to the proteins and thus
making those binding sites unable to interact with any destabilizing influences [6]. Additionally,
while the proteins are bound to calnexin or calreticulin, they can also recruit ERp57, an
oxidoreductase that assists in forming disulfide bonds that guide the glycoprotein to its native
state [6]. While this process generally allows proteins to reach their native states, in cases where
it is not sufficient the glycan chain can be further modified by mannosidase trimming to mark the
protein for further folding assistance by lectin chaperones [6]. When the additional folding
attempts are still not sufficient to reach the native state, the terminally misfolded proteins can
have their glycans marked to be targeted for the Endoplasmic Reticulum-Associated Degradation
(ERAD) pathway, which will be detailed next [9].
ERAD
ERAD is a principal ER quality-control process that prevents the accumulation and
aggregation of misfolded proteins by retrotranslocating them from the ER to the cytosol for
proteasomal degradation [10]. By this method ERAD, alongside the unfolded protein response
(UPR), maintains homeostasis in the cell [11]. In particular, Sel1L-Hrd1 ERAD is the most
evolutionarily conserved form of ERAD from yeast to mammals [12]. Sel1L (Sel-1 suppressor of
lin-12-like) serves as an adaptor of ERAD E3 ligase, while Hrd1 (HMG-CoA reductase
degradation 1) is an E3 ubiquitin-protein ligase [13]. Misfolded proteins are recruited by various
chaperone proteins and the Sel1L adaptor based upon their conformation or glycosylation state,
then Hrd1 serves as a channel to retrotranslocate them to the cytosol and ubiquitylates the
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proteins to mark them for proteasomal degradation [14]. An example of ERAD’s quality control
functionality is with null NHK (Hong Kong α1-antitrypsin), a terminally misfolded mutant form
of α1-antitrypsin and notable ERAD substrate. NHK is identified as misfolded by the ER lectin
OS9 (osteosarcoma amplified 9), which is scaffolded to the chaperones BiP (Binding
immunoglobulin Protein) and GRP94 (Glucose-Regulated Protein 94), or by the ER lectin
XTP3B (XTP3-transactivated gene B), wherein NHK is recruited to the Sel1L-Hrd1 complex for
degradation [15].
Furthermore, while ERAD is most commonly associated with its quality control process
of removing defective proteins, there is evidence that it can also serve a purpose in quantity
control of properly folded substrates in order to prevent their excessive accumulation. One
prominent example of this functionality is in the regulation of IRE1α (Inositol-Requiring
transmembrane kinase/Endoribonuclease 1α), which is a sensor of the UPR that was shown to
accumulate when Sel1L was knocked out to the detriment of the cell [16]. Much like in the
quality control process, ERAD of IRE1α is dependent on its association with a chaperone
protein, in this case BiP, which targets IRE1α for ERAD and assists in its recruitment to the
ERAD machinery [16]. By protecting the cells from the gain-of-function effects that can occur
from the overabundance of various ERAD substrates, this additional function of ERAD also
contributes greatly to maintaining homeostasis [17].
Chaperone Proteins in ERAD
There are several chaperone proteins that play roles in ensuring that ERAD can function
as intended, with the most important for the purposes of this investigation being BiP, GRP94,
OS9, and XTP3B.
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BiP is a highly evolutionarily conserved member of the Hsp70 family of proteins that
plays a diverse set of roles in the ER [6]. Assisting in the translocation of polypeptide chains,
managing improperly folded protein aggregation, facilitating proper protein folding, and
retrotranslocating proteins to the cytosol are just a few of BiP’s many responsibilities, in addition
to its role in ERAD processes [6]. In order to play a part in ERAD, BiP docks with a scaffold
complex comprised of Sel1L, Hrd1, and a pair of ER lectins, OS9 and XTP3B, which allows BiP
to facilitate the retrotranslocation of its substrate via the pathway provided by the Sel1L-Hrd1
complex [18].
GRP94 is a glycoprotein and is the only member of the Hsp90 family of proteins to reside
in the ER [19]. GRP94 typically binds with proteins that do not reach their native conformation
after the proteins bind and are released by BiP and promotes the advanced stages of folding
needed for the intermediates to reach their final conformations [19]. Additionally, GRP94 is
believed to play a major role in ERAD, as GRP94-deficiency was shown to inhibit ERAD, but
little is known about the exact method by which it facilitates ERAD beyond the fact that it
interacts with the lectin chaperone OS9 [15].
OS9 and XTP3B are ER lectins that can recognize glycan signatures indicating misfolded
glycoproteins and then interact with the proteins’ hydrophobic residues to transport them and
link them to Sel1L-Hrd1 ERAD for degradation [20]. OS9 and XTP3B are believed to interact
with their substrates through interactions with BiP or GRP94, and then link the substrates to
Sel1L [21]. Notably, while XTP3B has one main isoform of relevance, OS9 has two isoforms,
called OS9.1 and OS9.2, that have been shown to have varying relative abundances in different
cell samples [22]. Despite those observed differences, both isoforms were confirmed to interact
with Sel1L and GRP94 similarly [15]. However, OS9.2 is the isoform that is present in
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HEK293T cells in greater abundance in periods of ER stress [23], and thus appears to be more
relevant to ERAD regulation.
The relationships between OS9, XTP3B, and ERAD have been a matter of disagreement
in prior research, as several investigations into these components of ERAD led to varying results
that did not agree with other papers in the field. In some experiments, OS9 was found to be
essential for glycoprotein ERAD, while XTP3B was considered to be unnecessary for ERAD
when testing the ERAD substrates CD147 [24], NHK [25], and both the wild type and mutant
N278A forms of sonic hedgehog [26]. In another investigation, OS9 and XTP3B were found to
be functionally redundant when acting upon ERAD substrates detached from the ER membrane
[27]. An additional study found XTP3B to oppose OS9 and inhibit the ERAD of NHK when it
was marked with an M9 glycan [28].
Due to the varied results in prior published works, a recent study suggested that these
lectins have different substrate specificity for ERAD, broadly splitting proteins into three classes
based upon their glycosylation state and the effects knockouts of OS9, XTP3B, or both combined
in a cell line had upon the degradation of the substrate [29]. The first, Class A, is comprised of
glycoproteins that are recruited for ERAD in a glycan-dependent manner such as CD147 [29].
For Class A glycoproteins, OS9 and XTP3B act in a redundant manner, so ERAD can
successfully degrade its substrates when either OS9 or XTP3B is functional [29]. Conversely,
Class B proteins, such as A1ATNHK-QQQ, are not glycosylated, and the lectins act antagonistically,
so substrate degradation will only occur if either both or neither of the lectins are functional [29].
The third class of proteins, Class C, are N-glycosylated but are targeted in both glycosylated and
non-glycosylated regions, with a prominent example being HLA-C [29]. Interestingly, for Class
C proteins OS9 and XTP3B together can play a redundant, but not necessary, role in substrate
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degradation, as substrates are partially stabilized when both lectins are knocked out [29].
Additionally, XTP3B may inhibit the activity of OS9 in Class C proteins, as the knockout of
XTP3B led to increased substrate degradation [29]. However, the study only investigated a small
number of artificial substrates, so how OS9 and XTP3B regulate other ERAD substrates is still
unclear. Given the diverse relationships between OS9, XTP3B, and their potential substrates, the
substrate-specific function of OS9 and XTP3B warrants further investigation.
Iron Metabolism and Ceruloplasmin
Iron is a key mineral in the human body necessary for the health and survival of cells, but
it is also a toxic material that can cause great harm when in abundance, and thus necessitates
careful regulation throughout the body to maintain human health [30]. When a human ingests
iron as part of its diet, that iron is absorbed by mucosal cells lining the intestines in its ferrous
(Fe2+) state, then is converted to ferric iron (Fe3+) in order to bind to transferrin (Tf) [31]. As its
name suggests, transferrin serves the role of transferring the ferric iron by carrying it in the blood
and binding with Tf receptor 1 (TFR1) on the surface of cells in need of iron, which then
internalize the iron-loaded transferrin [32]. Additionally, iron can be transferred via the portal
vein to the liver to be stored in the hepatocytes for potential future use [33]. As the hepatocytes
regulate systemic iron levels [34], under iron deficiency this stored iron is exported from
hepatocytes to the tissues in need [35].
One key issue in iron metabolism is that, while tissues absorb iron in its ferrous state, it
can only be bound to transferrin as ferric iron. Thus, the protein that facilitates that conversion in
the liver, ceruloplasmin (Cp), plays an important role in iron metabolism [36].
Ceruloplasmin is a secreted ferroxidase produced by the hepatocytes that assists in the
transport of iron throughout the human body [37]. It does so via copper-dependent oxidation of
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iron from ferrous (Fe2+) to ferric (Fe3+) [38]. While Cp is only produced in the liver, it is required
for iron export in other cell types, and thus is secreted in the blood to be used by other tissues
[39]. This makes Cp a central part of systemic iron metabolism.
Aceruloplasminemia
Aceruloplasminemia is a human autosomal recessive disorder caused by mutations in Cp
that lead to improper Cp synthesis [40]. This Cp deficiency prevents the oxidation of iron needed
for it to be loaded onto transferrin, so iron cannot be used properly, causing anemia.
Additionally, the iron, as it cannot be bound to transferrin, builds up in various organs, with the
most troubling being a toxic buildup occurring in the brain [41]. The buildup of iron in the
organs has been connected to ailments like liver cirrhosis, neurodegeneration, diabetes, and
blindness [42]. Aceruloplasminemia is an adult-onset disease, but early signs like anemia can
manifest decades before the more severe neurological effects become discernible [42]. The
condition is frequently the result of a single missense mutation, and there have been various
mutations that have been shown to lead to aceruloplasminemia [43]. The missense mutation to be
studied as a representative of aceruloplasminemia in this investigation is G176R, as it has been
reported that the G176R mutation causes Cp to be retained in the ER [44]. However, the
molecular events underlying its biogenesis and degradation in the ER remain unexplored.
Project Background
In a previous, not yet published study from our lab, the resulting data suggested that the
biogenesis of Cp in the ER was regulated by Sel1L-Hrd1 ERAD. This was accomplished as part
of an assay carried out to identify hepatocyte-specific endogenous Sel1L-Hrd1 ERAD substrates.
ER fractions were purified from the livers of wild type (WT) and Sel1L-deficient mouse
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littermates and then analyzed by quantitative liquid chromatography with tandem mass
spectrometry.
Among the proteins identified, Cp was found to be highly accumulated in the ER of
Sel1L-deficient liver, suggesting that Cp is a potential substrate degraded by Sel1L-Hrd1 ERAD.
Indeed, it was found that Cp protein is highly elevated in Sel1L-deficient livers, independent of
transcriptional regulation (Figure 1A and not shown). Consistent with the elevated Cp protein
level, Sel1L-deficient mice had reduced liver iron content (Figure 1B), indicating that Sel1LHrd1 ERAD plays a role in regulating iron metabolism via Cp. Furthermore, the degradation of
both WT and mutant G176R Cp protein is abolished in Hrd1-deficient cells, confirming Cp as a
bona fide ERAD substrate (Figure 1C and 1D). However, the molecular mechanism underlying
ERAD-mediated Cp degradation remains unknown.
Given that Cp is a glycosylated protein, combined with the potentially distinct roles of
OS9 and XTP3B in regulating ERAD of glycoproteins, we aim to investigate the function of
OS9 and XTP3B in recruiting a disease-causing Cp mutant G176R for ERAD. We hypothesize
that OS9 and/or XTP3B is required for the recruitment, ubiquitination, and degradation of CpG176R.
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Figure 1. Preliminary Data: Cp is a Sel1L-Hrd1 ERAD substrate.
(A) Western blot analysis of WT and Sel1L-/- livers showing that Cp levels are elevated
in liver cells in the absence of Sel1L.
(B) Quantification of iron content in the livers of WT and Sel1L-/- mice, showing that
the presence of iron is reduced in the absence of Sel1L. WT n=5, Sel1LAlbCre n=7.
* indicates p<.05 by Student’s t-test.
(C-D) Western blot analysis of WT and Hrd1-/- HEK293T cells transfected with a CpFlag (C) or Cp-G176R-HA (D) expressing plasmid, showing that Cp and the G176R
mutant stabilize in the absence of Hrd1.
Both the blot images in (A), (C), and (D) and the quantitative data in (B) were provided
by the Sun lab and were used with the permission of the experimenters, Dr. Shengyi
Sun and Pattaraporn Thepsuwan. The data is not yet published as of May 2021.
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Chapter 2- Experimental Methods
Culturing Conditions
All cells were cultured at 37°C, 5% CO2 in a Fisherbrand Isotemp CO2 Incubator. The
medium used for the cultures was Dulbecco’s Modified Eagle Medium (DMEM) +4.5g/L DGlucose, +L-Glutamine, -Sodium Pyruvate with 10% Fetal Bovine Serum (FBS) and 1%
Penicillin Streptomycin added.
Generation of Single and Double Knockout Cell Cultures via CRISPR/Cas9
A plate containing a culture of Lenti-X 293T cells was grown to a high confluency (~7080%). Then, the plate was treated with 1.5mL 0.25% Trypsin-EDTA to detach the cells from the
plate and was added to tube with DMEM medium to a final volume of 10mL. Using a
hemacytometer, the concentration of cells per mL was determined, and this value was used to
calculate the volume of cells to add to DMEM in order to have a final cell concentration of 600K
cells/well of a 6 well dish and a final volume of 2mL/well. For each target plasmid to be used, 3
wells of a 6 well dish were prepared.
After growing in DMEM medium for one day, the Lenti-X 293T cells were transfected
with packaging and target plasmids. Per well, 100µL of Opti-MEM® medium (+HEPES,
+2.4g/L Sodium Bicarbonate, +L-Glutamine), 3µL FuGENE® HD Transfection Reagent, and
1µg of DNA (0.5µg target plasmid, 0.3µg psPAX2 and 0.2µg pMD2 packaging plasmids) were
prepared in a tube. Then, they were mixed via vortexing and incubated at room temperature for 8
minutes. After incubation, each well was refreshed with fresh DMEM medium, and then 100µL
of the mixture was added to each well.
After being left to grow for 48 hours, refreshing the medium after the first 24 hours, a
p1000 pipette was used to collect the medium of each lentivirus. This was stored overnight at
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4°C, and the medium was replaced with fresh DMEM. On the same day, human embryonic
kidney (HEK293T) cells were seeded into a well of a 6 well dish to serve as recipient cells for
each different target plasmid, along with an additional well to be used as a negative control. Each
well was seeded with 1/18 of a full (confluency>70%) 10cm dish of HEK293T cells.
The next day, the lentivirus medium was again collected by a p1000 pipette and pooled
with the medium collected for the same target from the prior day. Then, each tube of media was
filtered by passing it through a 10mL syringe with a 0.45µm SFCA sterile filter into a fresh
conical tube. Then, the DMEM media was removed from each well of recipient cells, and the
cells were infected by adding a combination of 1mL DMEM media, 1mL filtered lentivirus
media, and 8µg/µL polybrene to each well. The remaining lentivirus media was stored in 1.2mL
aliquots and then was flash frozen with liquid nitrogen and stored at -80°C. The recipient cells
were then left to grow.
After spending 48 hours growing, with the DMEM media refreshed after 24 hours,
recipient cells were transferred to 10cm dishes filled with DMEM and 1µg/µL puromycin, which
served to eliminate any uninfected cells, as the target DNA sequences also provided puromycin
resistance. After 24 hours, the plates were refreshed with new media and puromycin. 24 hours
after that, the plates were inspected to determine if the infection was successful by confirming
the presence of healthy cells despite the puromycin treatment. At this point, the negative control
plate was typically dead, so those cells were disposed, while the surviving infected cells were
passed into new 10cm dishes.
In 2-3 days, the plates reached sufficient confluency (~70%) to be used in testing
protocols and to freeze stocks to store for future use. For frozen storage, the samples were spun
down for 3 minutes at 120xg in a Sorvall Legend RT centrifuge, the DMEM medium was
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removed, and the pellets were resuspended in freezing media (90% DMEM+10% DMSO). They
were then aliquoted 1mL each into cryovials and placed in a Nalgene Cryo 1°C Freezing
Container. The Freezing Container was then left in a -80°C freezer overnight. Finally, the frozen
cryovials were transferred to be stored in liquid nitrogen.
CHX Pulse-Chase Assay to Examine Protein Degradation
Plates containing cultures of HEK293T cells of WT or the chosen knockout were grown
to a high confluency (~70-80%). Then, each plate was treated with 1.5mL 0.25% Trypsin-EDTA
to detach the cells from the plate and were added to tubes with DMEM medium to a final volume
of 10mL. Using a hemacytometer, the concentration of cells per mL was determined, and this
value was used to calculate the volume of cells to add to DMEM in order to have a final cell
concentration of 600K cells/well of a 6 well dish and a final volume of 2mL/well. Each sample
was grown and tested in duplicate.
After growing overnight, the cells were transfected with either WT or G176R mutant Cp
HA-tagged overexpression plasmids, 0.5µg per well of a 6 well dish. To accomplish this, two
diluents were prepared, one for PEI, another for the plasmid. For the PEI diluent, 100µL of OptiMEM® and 16µL 1x PEI were added for each well that would be transfected. For each plasmid
diluent, 100µL of Opti-MEM® was mixed with the necessary amount of plasmid DNA to reach
the desired concentration. When both diluents were prepared, equal volumes of each were added
together, mixed via vortexing, and left at room temperature for 15 minutes. After this time was
finished, the medium in each well was refreshed with fresh DMEM, and then 200µL of the
transfection mix was added to each well, and the plates were gently shaken to properly distribute
the mix. They were then left to grow overnight.
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The next day, the transfected cells would undergo the CHX pulse-chase assay. First, each
well was refreshed with DMEM that contained 1µg/mL BFA for a 30-minute pretreatment.
Then, at the time appropriate for the desired treatment timepoint, CHX was added to a
concentration of 150µM. Upon completion of the treatment period, the media was removed from
the wells, and they were placed on ice to undergo cell lysis.
To lyse the cells first Radio-Immunoprecipitation Assay (RIPA) Buffer was added
(50mM pH7.5 Tris, 150mM NaCl, 2mM EDTA, 1% NP40, 0.2% Sodium Deoxycholate, 0.1%
SDS) along with 1µM DTT and 1µL/mL PI (Sigma P8340), with a total of 120µL of the mix
added to each well. Each well was scraped to dislodge the cells, and then they were collected in a
microfuge tube and spun at 4°C, 14,000rpm for 5 minutes in an Eppendorf 5424R Centrifuge.
80µL of clear lysate was collected in a fresh microfuge tube, then 20µL of 5x SDS Sample
Buffer + ßMercaptoethanol (250mM pH6.8 Tris, 10% SDS, 0.05% Bromophenol Blue, 1.44M 2Mercaptoethanol, 50% Glycerol in ddH2O) was added to each tube. Each sample was then mixed
by vortexing and boiled at 95°C for 5 minutes. After boiling, the samples were used for Western
Blotting, and the remaining volumes were stored at -20°C.
Immunoprecipitation Protocol (Native Only)
Plates containing cultures of HEK293T cells of WT or the chosen knockout were grown
to a high confluency (~70-80%). Then, each plate was treated with 1.5mL 0.25% Trypsin-EDTA
to detach the cells from the plate, any identical plates were pooled together, and the cells were
added to tubes with DMEM medium to a final volume of 10mL. Using a hemacytometer, the
concentration of cells per mL was determined, and this value was used to calculate the volume of
cells to add to DMEM in order to have a final cell concentration of 3.2M cells/10cm dish and a
final volume of 10mL/dish.
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After growing overnight, the cells were transfected with the desired plasmids for testing,
typically utilizing 3µg of a ubiquitin overexpression plasmid and 6µg of either WT or G176R
Mutant Cp HA-tagged overexpression plasmids. To accomplish this, two diluents were prepared,
one for PEI, another for the plasmid. For the PEI diluent, 500µL of Opti-MEM® and 80µL 1x
PEI were added for each plate that would be transfected. For each plasmid diluent, 500µL of
Opti-MEM® was mixed with the necessary amount of plasmid DNA to reach the desired
concentration. When both diluents were prepared, equal volumes of each were added together,
mixed via vortexing, and left at room temperature for 15 minutes. After this time was finished,
the medium in each plate was refreshed with fresh DMEM, and then 1mL of the transfection mix
was added to each plate, and the plates were gently shaken to properly distribute the mix. They
were then left to grow overnight.
The next day, the cells underwent treatment of 5µM MG132 for 3 hours to inhibit
proteasomal activity. Upon completion of the treatment period, the media was removed from the
dishes, and they were placed on ice to undergo cell lysis.
To lyse the cells first NP40 Lysis Buffer was added (150mM NaCl, 1mM EDTA, 50mM
Tris pH7.5, 1% NP40) along with 5mM N-Ethylmaleimide (NEM) and 1µL/mL PI (Sigma
P8340), with a total of 800µL of the mix added to each dish. Each dish was scraped to dislodge
the cells, and then they were collected in microfuge tubes and sonicated twice for 5 seconds
each. After sonication, they were spun at 12,000xg, 4°C for 10 minutes in an Eppendorf 5424R
Centrifuge. 700µL of the clear lysate was collected in fresh tubes, and then the concentration of
protein was determined through a Bradford assay.
For the Bradford assay, 1µL of lysate was added to 1mL of Bio-Rad Protein Assay Dye
Reagent Concentrate (from Bio-Rad, diluted 1:5 for use). Additionally, 6 standards of known
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protein concentration were prepared alongside the samples to produce a standard curve. These
prepared samples were added into wells of a 96 well plate, and then a BioTek Synergy H1
microplate reader was used to read the absorbance of the samples at 595nm. The sample readings
were compared to the standard curve to determine their concentrations, and then the previously
prepared NP40 Lysis Buffer was added to the samples as needed to standardize the
concentrations to the same value.
Once the samples’ concentrations were standardized, 60µL of sample was removed from
each to be used as an input and added to 15µL 5x SDS Sample Buffer + ßMercaptoethanol in a
fresh tube. Each sample was then mixed by vortexing and boiled at 95°C for 5 minutes. After
boiling, the samples were stored at -20°C.
The remaining volume of sample not used to prepare the input was mixed with 10µL
ProA 20% agarose beads to reduce the background. These samples were spun (10 seconds per
rotation) on a ThermoScientific Tube Revolver at 4°C for 1 hour, and were then spun 6,000rpm,
4°C, 1 minute in an Eppendorf 5424R Centrifuge. 600µL of the cleared lysate was collected in
new microfuge tubes, and 20µL 20% anti-HA agarose beads were added to each sample. Finally,
the samples were spun (10 seconds per rotation) on a ThermoScientific Tube Revolver at 4°C
overnight.
To wash and elute the samples, the samples were spun 3,000rpm, 4°C, 1 minute in an
Eppendorf 5424R Centrifuge, as much supernatant was removed as possible without disturbing
the pellet, 1mL NP40 Lysis Buffer with 1µL/mL PI (Sigma P8340) was added to each tube, and
they were gently inverted 5 times while on ice. This process was then repeated 3 additional
times, but with 1mL NP40 Wash Buffer (1% NP40, 10% Glycerol, 137mM NaCl, 2mM EDTA,
20mM Tris pH7.5) added to the samples instead of NP40 Lysis Buffer.
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After the 4 wash cycles were performed, the samples were again spun 3,000rpm, 4°C, 1
minute in an Eppendorf 5424R Centrifuge to allow a pellet to form. Then, as much supernatant
was removed as possible without disturbing the pellet, with care being taken to ensure that each
sample had roughly the same remaining volume. Then 55µL 1.5x SDS Sample Buffer +
ßMercaptoethanol was added to each sample and they were mixed by vortexing and boiled at
95°C for 5 minutes. The boiled samples were spun 6,000rpm for 2 minutes at room temperature
in an Eppendorf 5424R Centrifuge, 50µL of sample was collected into a new tube, the samples
were spun again to confirm that there would no longer be a visible pellet, and then the samples
were used for Western Blotting, with the remaining volumes stored at -20°C.
Immunoprecipitation Protocol (Native and Denatured)
Preparation of cells for both Native and Denatured samples was identical to that of Native
Only preparation until the point of cell lysis.
To lyse the cells NP40 Lysis Buffer was added along with 5mM NEM and 1µL/mL PI
(Sigma P8340), with a total of 1mL of the mix added to each dish. Each dish was scraped to
dislodge the cells, and then they were collected in microfuge tubes and sonicated twice for 5
seconds each. After sonication, they were spun at 12,000xg, 4°C for 10 minutes in an Eppendorf
5424R Centrifuge. 900µL of the clear lysate was collected in fresh tubes, and then the
concentration of protein was determined through a Bradford assay, which was performed
identically to that described in the Native Only preparation method. The samples had their
concentrations standardized and had a 60µL removed and prepared for use as an input in the
same manner as that described in the Native Only preparation method.
The remaining volume of sample not used to prepare the input was split into 2 aliquots,
one 300µL to be used for the Native IP, and the other 500µL to be used for the Denature IP.
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The Native IP samples had 10µL 20% anti-HA agarose beads added to each of them, and
the samples were spun (10 seconds per rotation) on a ThermoScientific Tube Revolver at 4°C
overnight.
The Denatured IP samples had 50µL 10% SDS (final concentration 1%) and 2.5µL of
1M DTT (final concentration 5mM) added to each. Then, the samples were mixed by vortexing
and boiled at 95°C for 10 minutes. After boiling, the samples were transferred to a fresh 15mL
centrifuge tube and 8.3mL NP40 Lysis Buffer with 1µL/mL PI (Sigma P8340) was added to
each sample. The samples were mixed by vortexing, and then 40µL 20% anti-HA agarose beads
were added to each sample. Finally, the samples were spun (10 seconds per rotation) on a
ThermoScientific Tube Revolver at 4°C overnight.
The next day, to prepare the Denatured IP samples for washing and elution, they were
spun 850xg, 4°C, 1 minute in a Sorvall Legend RT centrifuge. The majority of the supernatant
was removed, but a small remainder of the volume (<100µL) was used to resuspend the pellet
and transfer it to a fresh microfuge tube. Then, 800µL NP40 Lysis Buffer with 1µL/mL PI
(Sigma P8340) was added to wash the sides of the centrifuge tubes and collect any beads
potentially adhering to them, which was then added to the previously collected material.
At that point, the washing and elution procedures for both Native and Denatured IP
samples were performed identically to how they were described in the Native Only preparation
method.
Acrylamide SDS-Page Gel Preparation
Gel mix was prepared with the desired percentage of acrylamide (either 6% or 8%)
diluted from a 30% acrylamide stock, 375mM pH8.8 Tris, 0.1% SDS, 0.1% APS, ddH2O and
either 8µL (6%) or 6µL (8%) N,N,N’,N’-tetramethylethylenediamine (TEMED) at a total
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volume of 10mL per gel. 9mL of this mix was added into a gel cast for each gel made. 700µL of
95% ethanol was pipetted across the top of the gel to ensure it distributed evenly, and the gel was
left for 30 minutes to set.
After the gel set, the ethanol was poured out and the top of the gel was washed with
ddH2O to remove any remaining ethanol, after which it was dried with filter paper. Then, a gel
mix called the stacking gel, which was prepared with 5% acrylamide, 285mM pH6.8 Tris, 0.1%
SDS, 0.1% APS, and 5µL TEMED at a total volume of 1.5mL per gel, was added to the gel cast
with a p1000 pipette, 1.5mL per gel, and a 15 well 1.5mm gel comb was added to each gel. The
gel was again left to set for 30 minutes, and then was wrapped in wet paper towels and stored in
a resealable plastic bag at 4°C.
Western Blotting
SDS-Page gels were assembled within a Bio-Rad Mini-PROTEAN Tetra cell
electrophoresis module filled with Tris-Glycine Running Buffer (14.4g/L glycine, 3g/L Tris
Base, 1g/L SDS in ddH2O). Then, samples were loaded (typically 10µL/lane) in each lane
alongside Bio-Rad Precision Plus Protein All Blue Standards to serve as a ladder. Gel
electrophoresis was then carried out at 140V until the visible sample band neared the bottom of
the gel (approximately 60 minutes).
To transfer the protein from an SDS-Page gel to a polyvinylidene difluoride (PVDF)
membrane, a Bio-Rad Tetra Blotting module was utilized. First, the PVDF membrane was
soaked in methanol for 30 seconds to activate it, and then it was placed in Tris-Glycine Transfer
Buffer (14.4g/L glycine, 3g/L Tris Base in ddH2O) to equilibrate. During equilibration, the gel
was removed from the electrophoresis module and the stacking gel was removed. Then, a
transfer cassette was submerged in Transfer Buffer, and inserted in the cassette were, in order, a
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fiber pad, a piece of filter paper, the gel, the PVDF membrane, another piece of filter paper, and
another fiber pad. The cassette was then closed and placed into the transfer cell. The transfer cell
was then filled with Transfer Buffer, enclosed in ice to control the temperature, and then the
transfer was carried out at 90V for 60 minutes.
After transfer was complete, the PVDF membrane was removed from the transfer
cassette, rinsed in TBST for 2 minutes, and then probed with the chosen primary antibody
overnight at 4°C.
The next day, the membrane was washed in TBST for 30 minutes. Then, it was probed
with secondary antibody (either αrabbit or αmouse) for one hour. After the secondary probe, it
was washed for another 30 minutes. Then, to develop the membrane, a 1:1 mix of Bio-Rad
Clarity™ Western ECL Substrate peroxide solution and luminol/enhancer solution was pipetted
onto it. After 5 minutes, then membrane was then imaged with a Bio-Rad ChemiDoc Imaging
System. Chemiluminescent images were used to gather visual data of the bands of protein, which
were juxtaposed with the colorimetric images of the ladder to determine the size of the bands.
These images were then analyzed in the Bio-Rad Image Lab™ software.
Statistical Analysis of Data
Western Blot data was analyzed and quantified utilizing the Bio-Rad Image Lab™ 6.0.1
software. All quantification was of relative values of each band volume in an image, with the
most intense band signal on the blot serving as the reference band. Then, all of the test sample
readings were normalized to their respective loading controls.
Processed data across multiple experimental repeats of the CHX-Pulse Chase Assay were
analyzed by a two-way repeated measures ANOVA of the cell type vs time of treatment for CHX
tests performed using SAS® Studio. A Bonferroni post-hoc test was then applied to the resulting
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ANOVA data in order to determine the significance of the variance between the cell samples at
each collected timepoint, with adjusted values of p<.05 being considered significant. Plotted data
uses the mean values ± SEM and graphs were created utilizing the Microsoft Excel software.
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Chapter 3-Results
Cp-G176R interacts with endogenous OS9 and XTP3B
To determine if Cp-G176R could be regulated by OS9 or XTP3B, we first examined if
either lectin interacted with Cp. We transfected HEK293T cells with a plasmid overexpressing
HA-tagged Cp-G176R and measured the interaction between Cp-G176R, Sel1L, OS9, and
XTP3B by co-immunoprecipitation. We detected an interaction between Cp-G176R and Sel1L,
as well as between Cp-G176R and XTP3B in WT cells (lane 1 and 2, Figure 2A).
As the interaction between the substrate and ERAD machinery is potentially transient, we
attempted to stabilize the interaction by using Hrd1-deficient HEK293T cells (Hrd1-/-). In the
absence of Hrd1, endogenous ERAD substrates, including Sel1L and OS9 are stabilized (lane 5,
6 vs 7, 8, Figure 2A) [45]. Indeed, we found that Cp-G176R interacted much more strongly with
Sel1L, OS9, and XTP3B in Hrd1-/- cells (lane 4, Figure 2A).
To confirm that these interactions would be consistent in Cp models, the testing process
was repeated with HEK293T cells with a plasmid overexpressing the HA-tagged WT Cp and
measured the interaction between Cp, Sel1L, OS9, and XTP3B. Again, interactions were
detected between Cp and Sel1L, XTP3B and OS9 in the WT (lane 2, Figure 2B) and Hrd1deficient cells (lane 4, Figure 2B). However, all of the interactions were much weaker than CpG176R with the same substrates.
Together, we conclude that Cp-G176R interacts with endogenous Sel1L, OS9, and
XTP3B, suggesting that these ERAD machineries may mediate its degradation. Next, we
examined whether OS9 and/or XTP3B is required for the ERAD of Cp-G176R.
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Figure 2. Cp-G176R interacts with endogenous OS9 and XTP3B
Western blot analysis of immunoprecipitates of HA-agarose in WT and Hrd1-/- HEK293T
cells transfected with Cp-G176R-HA (A) and WT Cp (B). Blots for the
immunoprecipitated samples are on the left, while blots for the input are on the right. Cells
were treated with proteasome inhibitor MG132 for 3 hours prior to immunoprecipitation.
The tests were repeated once to confirm the results.
CRISPR/Cas9 effectively knocked out XTP3B and OS9.2, but not OS9.1
To generate knockouts of OS9 and/or XTP3B we utilized CRISPR/Cas9 gene editing
technology. CRISPR/Cas9 allows for precision gene editing by making cuts to DNA with the
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Cas9 enzyme that are targeted by being bound to guide RNA (gRNA) [46]. By making the cuts
indicated by the gRNA and having them repaired with non-homologous end joining, the desired
knockout can be generated. Furthermore, the lentivirus used to deliver the Cas9 and gRNA also
inserts DNA that overexpresses the puromycin resistance gene, a capability that we utilized in
these experiments to provide a drug resistance that allowed us to select for cells that contain the
lentivirus. The gRNAs used for this process are listed in Table 1.
Single and Double Knockout HEK293T embryonic kidney cells were cultured and
prepared as described in the Experimental Methods section. For each lectin to be knocked out,
OS9 or XTP3B, we used two different guide RNAs in tandem to generate the desired knockout.
To confirm the success of each knockout, samples were examined by Western Blot analysis.
Name
OS9-/-1
OS9-/-2
XTP3B-/-1
XTP3B-/-2

Guide Sequence
ttacccgcaagtctgaccgg
tgtcgggagcctgaacctgg
ccggtgttactggtcctctg
acttccccttgtgacaagtg

Table 1. Guide Sequences for CRISPR/Cas9
The guides were utilized in conjunction with LentiCRISPR v2 Cas9 to edit the target sequence.
In the OS9 single knockout tests, both guides effectively knocked out the second isoform
of OS9, labelled OS9.2, but the first of the two guides, marked as OS9-/-1, displayed a slightly
more complete knockout of all the cells tested (Figure 3A). However, neither of the guides
displayed a complete knockout of the first isoform, OS9.1. It remains unclear why OS9.1 is not
affected by the CRISPR guide RNAs. The loss of OS9.2 did not affect Sel1L or Hrd1 protein
levels (Figure 3A). For subsequent experiments, OS9-/-1 was selected.
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In the XTP3B single knockout tests, both guides knocked out XTP3B, but the first guide,
marked as XTP3B-/-1, was notably more effective (Figure 3B). Therefore, XTP3B-/-1 was
selected for subsequent tests. Sel1L protein was not affected by the loss of XTP3B (Figure 3B).
Using the more effective guides towards OS9 and XTP3B, we generated XTP3B/OS9.2
double knockout (DKO) HEK293T cells. As shown by the Western blots, the double knockout
cells exhibit an efficient knockout of OS9.2 and XTP3B, comparable to single knockout cells
(Figure 3C). Interestingly, the loss of OS9.2 led to an accumulation of XTP3B protein,
suggesting OS9 is required by XTP3B degradation (lane 2, Figure 3C). Other key proteins for
ERAD and UPR, such as Sel1L and Ire1a were not affected by the loss of OS9.2 and XTP3B,
excluding a profound effect on ER homeostasis and stress or Sel1L-Hrd1 ERAD deficiency.
Together, the generation of OS9.2 and XTP3B single and double knockout cells allowed us to
next examine if one or both of these two lectins are required for the degradation of Cp-G176R.
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Figure 3. CRISPR/Cas9 effectively knocked out XTP3B and OS9.2, but not OS9.1
(A) Western blot analysis of HEK293T cells, each of which underwent gene editing by
CRISPR/Cas9 to produce a WT or a knockout of OS9 as targeted by one of two unique guide RNAs
(OS9-/-1 or OS9-/-2).
(B) Western blot analysis of HEK293T cells, each of which underwent gene editing by
CRISPR/Cas9 to produce a WT or a knockout of XTP3B as targeted by one of two unique guide
RNAs (XTP3B-/-1 or XTP3B-/-2).
(C) Western blot analysis of HEK293T cells, with the first three lanes being the previously generated
WT, OS9-/-, and XTP3B-/-, and the final lane containing cells that were targeted by both of the
previously selected guide RNAs (OS9-/-1 and XTP3B-/-1) to knockout both OS9 and XTP3B.

OS9 and XTP3B play a redundant role in Cp degradation
The OS9.2 and XTP3B single and double knockout cells that were successfully generated
in the prior experiment were then transfected with plasmids overexpressing the HA-tagged CpG176R mutant and were subjected to a Cycloheximide (CHX) Pulse-Chase Assay as described
in Experimental Methods, which would allow the stability of proteins in the samples to be
measured. CHX is a protein translation inhibitor used to suppress the synthesis of new proteins,
which allowed us to test the degradation rate of various proteins of interest. Additionally,
samples were also treated with Brefeldin A (BFA), which inhibited protein secretion.
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Interestingly, the loss of OS9.2 did not affect the stability of Cp-G176R with a half-life of
about 4 hours (Figure 4A), suggesting that XTP3B is sufficient for ERAD to degrade Cp. The
loss of XTP3B appeared to reduce stability after 3 hours of CHX treatment, yet returned to a
nearly identical degradation level at 6 hours (Figure 4B), which indicates that OS9 is also
sufficient for ERAD to degrade Cp. However, in OS9.2/XTP3B double knockout cells, CpG176R is significantly stabilized (Figure 4C). Together, these results suggest that the
degradation of Cp-G176R is dependent on ER lectins OS9.2 and XTP3B, with either one
sufficient

to

mediate

the

function.
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Figure 4. OS9 and XTP3B play a redundant role in Cp degradation
(A-C) Representative data of a Western blot analysis of Cp decay in cycloheximide (CHX)treated WT and OS9-/- (A), XTP3B-/- (B), or DKO (C) HEK293T cells transfected with a CpG176R-HA expressing plasmid, with quantitation shown below or alongside each. All cells
were treated with protein secretion inhibitor Brefeldin A (BFA) 30 minutes prior to CHX
exposure.
Quantitation results shown combining the results of six (A and C) or four (B) independent
repeats. Values given are the mean ±SEM.
Listed above the timepoints of the quantitation are the adjusted p-values of each as determined
by a two-way ANOVA and Bonferroni post-hoc test, with values of p<0.05 considered
significant, as indicated by a * and values of p<0.01 indicated by a **.
A two-way ANOVA was performed to examine the effects of the presence of knockouts and
the time of CHX exposure on the Relative Ceruloplasmin Level. The results observed were
significant for the XTP3B-/- at t=3 (F2,18=6.94, adjusted p<.01) and the DKO at t=6
(F2,30=3.05, adjusted p<.05). All other results were below the set significance threshold of
p<.05 for the adjusted p-value.

28

The ubiquitination of Cp-G176R is dependent on OS9.2 and XTP3B
As ERAD targets substrates for degradation via ubiquitination, we next measured the
ubiquitination levels of Cp in wild type and OS9.2 and/or XTP3B knockout HEK293T cells.
Indeed, in WT HEK293T cells, transfected Cp-G176R is quickly polyubiquitinated (lane 1 vs. 2,
Figure 5A). The single deletion of XTP3B did not affect Cp-G176R polyubiquitination (lanes 3
vs. 2, Fig. 5A). On the contrary, the loss of both OS9.2 and XTP3B markedly attenuated CpG176R polyubiquitination (lanes 4 vs. 2, Fig. 5B). These results were further confirmed by the
immunoprecipitation of denatured protein lysate, excluding potential contamination of proteins
interacting with Cp-G176R (denatured IP, Fig. 5B). Together, these results suggest that CpG176R has a requirement of at least one ER lectin, OS9.2 or XTP3B, for efficient ERADmediated polyubiquitination.
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Figure 5. The ubiquitination of Cp-G176R is dependent on OS9.2 and XTP3B
(A-B) Western blot analysis of immunoprecipitates of HA-agarose in WT and XTP3B-/- (A)
or DKO (B) HEK293T cells transfected with a Cp-G176R-HA expressing plasmid as
indicated. Cells were treated with proteasome inhibitor MG132 for the last 3 hours prior to
immunoprecipitation.
In Native IP samples, the native structure of the protein is preserved, while Denatured IP
samples have SDS and DTT added and are then boiled to destroy the complex structure.
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Chapter 4- Discussion
Notably, OS9 had two isoforms visible on the Western Blot of the initial Cp interaction
experiment, OS9.1 and OS9.2. As both isoforms were visible in the Hrd1-/- Cp overexpressed
lane (lane 4, Figure 2), both could potentially be capable of complexing with Cp. For unknown
reasons, upon the attempt to knockout the ER lectins, while XTP3B’s knockout was highly
effective, only OS9.2 was efficiently deleted. This is not due to the target sites for the OS9-/guides as both were located on the first exon, which is conserved between all isoforms of OS9
[29]. Additional guides need to be tested for a complete deletion of OS9.1 and OS9.2.
Interestingly, the OS9.2 isoform is present in HEK293T cells in greater abundance
(Figure 2) [23]. In fact, a previous report showed that OS9.2 is more effective in maintaining
proper ERAD and mediating the degradation of glycoproteins than OS9.1 [29]. Therefore, we
continued our study to examine the roles of OS9.2 and XTP3B in mediating the ERAD of CpG176R. Indeed, we observed that the depletion of OS9.2 and XTP3B significantly attenuated the
degradation and ubiquitination of Cp-G176R (Figures 4C and 5B), suggesting that OS9.1 alone
is not sufficient for maintaining an efficient ERAD function in cells.
In OS9.2 single knockout cells, we observed an elevated protein level of XTP3B protein
(Figure 3C). It remains uncertain whether this increased XTP3B is due to its transcription
induction, or the blockage of its degradation. It is possible that XTP3B is transcriptionally
induced to compensate for the loss of OS9.2, thereby to maintain the ERAD function.
Alternatively, OS9.2 may be required for the ERAD degradation of XTP3B protein. These
possibilities require further studies. On the contrary, the expression of OS9 is not regulated by
XTP3B as seen in XTP3B single knockout cells (Figure 3C).

31

Overall, the observations of individual knockouts leaving Cp degradation unaffected,
barring the unexplained reduced stability of the XTP3B-/- t=3 point (Figure 4B), and the double
knockout causing a substantial stabilization of Cp combine to strongly support a redundant
relationship between OS9 and XTP3B in mediating the degradation of Cp-G176R. At first
glance, this result would appear to support the work that suggested that OS9 and XTP3B have a
redundant relationship when dealing with ERAD substrates not bound to the membrane [27],
while contradicting the studies that found only OS9 to be necessary for ERAD [24, 25, 26] and
the study that claimed XTP3B was antagonistic towards OS9 and inhibited ERAD [28].
However, based on the publication that segregated ERAD substrates into three classes based on
the requirement of ER lectins OS9 and XTP3B [29], the discrepancy in the necessity of OS9 and
XTP3B can be explained as being due to the varying substrate specificity of the lectins based
upon the classes of the substrates. In this case, based upon those guidelines our data indicates
that Cp-G176R should be classified as a Class A substrate, which is comprised of glycoproteins
that display redundant roles for XTP3B and OS9 in the degradation of the substrate via ERAD.
In the absence of individual lectins, the other ER lectin is sufficient in facilitating the ERAD of
Cp. However, when both lectins are absent, the degradation and ubiquitination of Cp-G176R is
partially abolished. Therefore, the degradation of Cp-G176R is strictly dependent on lectins and
glycan determinants.
Glycoproteins can also be degraded by ERAD based on both glycan and non-glycan
determinants, with these proteins being known as Class C substrates. An example of a Class C
substrate is HLA-C, a type 1 integral membrane glycoprotein that was only partially stabilized
when both OS9 and XTP3B were knocked out, thus indicating that they had redundant function
but were not necessary for the ERAD of the HLA-C, and furthermore displayed increased
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degradation when only XTP3B was knocked out [29]. Upon initially examining the results of the
Cp-G176R degradation experiments, the incomplete stabilization of Cp and the heightened
degradation of Cp in cells that had lost XTP3B at its earlier timepoint suggested the possibility of
Cp-G176R being either a Class A or Class C substrate. However, for Cp-G176R the single loss
of XTP3B did not accelerate its polyubiquitination, and the Cp level returned to that of the WT
after the full CHX treatment, thus eliminating the possibility that it could be a Class C substrate.
Collectively, our result establishes that OS9 and XTP3B are together necessary for the ERAD of
Cp-G176R based on its glycan signatures, but that each lectin is sufficient to mediate such a
function.
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Chapter 5- Conclusions and Future Directions
Our data indicated that the glycoprotein Cp-G176R was a Sel1L-Hrd1 ERAD substrate,
interacting with two ER lectins, OS9 and XTP3B. By generating single and double knockout
cells, we found the ERAD of Cp-G176R is dependent on its interaction with ER lectins OS9 and
XTP3B. Either lectin is sufficient to mediate the ubiquitination and degradation of Cp-G176R.
Our results showed that OS9.2 and XTP3B act redundantly for the ERAD of Cp-G176R,
suggesting that the degradation of Cp-G176R is dependent on glycan determinants [23]. The
requirement of mannose trimming of glycans in the ERAD of Cp-G176R should be further
examined by the use of kifunensine, an inhibitor of the glycoprotein-processing mannosidase I
[47]. It is possible that the interaction between Cp-G176R and ER lectins and therefore the
ERAD-mediated degradation of Cp-G176R may be abolished when the mannose trimming is
inhibited.
One troubling issue encountered in the course of these experiments was the inexplicable
inability of the gRNAs used for CRISPR/Cas9 to knockout the first isoform of OS9, despite the
fact that the targeted area is identical in both OS9 isoforms. Additional gRNAs targeting OS9 on
different exons that were conserved between the isoforms were later generated, but again failed
to successfully knockout OS9.1. If a gRNA proven to knockout OS9.1 and OS9.2 could be
acquired, the process used in this series of experiments could be replicated to determine whether
or not the first isoform of OS9 has any significant impact upon its ability to regulate Cp
degradation. Alternatively, other approaches such as siRNA or miRNA knockdown may be
employed to address the issue.
Given that OS9 and XTP3B interact with BiP and GRP94 to recruit substrates for ERAD,
it would be interesting to investigate the roles of BiP and GRP94 in the OS9/XTP3B-mediated
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recruitment of Cp-G176R for ERAD. The interaction between Cp-G176R and BiP/GRP94
should be examined in OS9, XTP3B, Hrd1 and Sel1L deficient cells. In addition, tests examining
the degradation and ubiquitination of Cp-G176R could be performed as shown in this study with
the manipulation of BiP and/or GRP94 expression levels in order to determine if they are
necessary for ERAD-mediated degradation of Cp.
As our investigations were mostly limited to the G176R mutant Cp, this testing process
could be repeated with WT Cp, as well as other disease-causing Cp mutations, in order to
investigate if the necessity of OS9 and XTP3B is consistent across Cp variants. In addition, to
directly address the clinical implications of our findings in the disease aceruloplasminemia,
future experiments should be performed in hepatocyte cell lines or primary hepatocytes, or in
vivo using mouse models, to examine whether the dysfunction in the ERAD pathway is linked to
the pathogenesis of disease-causing Cp mutations. Understanding the interaction between ERAD
machineries and Cp disease mutants will significantly advance our understanding of the
pathogenesis of aceruloplasminemia as well as other protein-misfolding diseases and pave the
foundation for future therapeutic efforts targeting these early folding and degradation events.
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Ceruloplasmin (Cp) is a secreted ferroxidase produced by the hepatocytes that assists in
the transport of iron throughout the human body. In human aceruloplasminemia patients, due to
Cp deficiency excess intracellular iron buildup leads to ailments like liver cirrhosis,
neurodegeneration, and blindness.
We recently found that the biogenesis of Cp in the endoplasmic reticulum (ER) is
regulated by a principal ER quality-control process, ER-associated degradation (ERAD). ERAD
clears misfolded ER proteins for cytosolic proteasomal degradation, with the Sel-1 suppressor of
lin-12-like (Sel1L)-HMG-CoA reductase degradation 1 (Hrd1) protein complex representing the
most conserved branch in mammals. Interestingly, we found that Sel1L-Hrd1 ERAD in
hepatocytes mediates the degradation of Cp, thereby regulating systemic iron homeostasis.
However, the molecular mechanism underlying ERAD-mediated Cp degradation remains
unknown.
Osteosarcoma amplified 9 (OS9) and XTP3-transactivated gene B (XTP3B) are lectins in
the ER that can recognize misfolded glycoproteins and transport them to Sel1L-Hrd1 ERAD for
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degradation. Here, we hypothesized that those two ER lectins, OS9 and XTP3B, mediate the
ERAD of Cp.
Using molecular and genetic approaches, we investigated whether and how OS9 and
XTP3B mediate the degradation of a Cp mutant G176R found in human aceruloplasminemia
patients. Specifically, we generated OS9- and/or XTP3B-deficient HEK293T cells using
CRISPR/Cas9 technology. We found that the loss of both OS9 and XTP3B, but not either
individually, leads to reduced ubiquitination and a stabilization of Cp, suggesting that the two
lectins play a redundant and essential role in the efficient ERAD of Cp. Together, by
investigating the molecular mechanism underlying the biogenesis of Cp, we provided novel
insights into the regulation of iron metabolism under pathological conditions.
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